Skip to content
Recall Observatory FDA recall evidence

Drug product

Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA, NDC 0378-5265-98.

D-0444-2017

December 20, 2016

Class II

Product summary

Firm
Mylan LLC.
Event
Event 76020
Status
Terminated
Classification
Class II
Quantity
588 bottles
Official record key
drug-enforcement:D-0444-2017

Official wording

Reason: Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.

Code information: LOT #: 2006912, Exp 02/18

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.